Identifying Epistatic Suppressors of Oncohistone in Pediatric High-Grade Gliomas |
BC Cancer (Provincial Health Services Authority) / Carol Chen, PhD |
Young Investigator Grants |
2020 |
British Columbia |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1 |
Northwestern University (Illinois) / Zibo Zhao, PhD |
Young Investigator Grants |
2018 |
Illinois |
The Role of PASG in Mediating Epigenetic Change and Outcome in AML.
|
The Johns Hopkins University School of Medicine / Jason Farrar, MD |
Young Investigator Grants |
2007 |
Maryland |
The Role of LIN28B-let-7-PBK Axis on the Growth and Metastasis of Group 3 Medulloblastoma |
Emory University / Shubin Shahab, MD/PhD |
Young Investigator Grants |
2021 |
Georgia |
Investigating Racial Disparities in Pediatric Acute Leukemia |
University of California San Francisco / Lena Winestone, MD |
Young Investigator Grants |
2016 |
California |
Exploiting WT1 Genomic Alterations for Target Identification and MRD Monitoring in Pediatric AML |
Fred Hutchinson Cancer Research Center / Phoenix Ho |
Young Investigator Grants |
2012 |
Washington |
Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Regina Myers, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
Elucidating the Roles of Aneuploidy in Down Syndrome-Associated Leukemia |
Boston Children’s Hospital / Chun-Chin Chen, PhD |
Young Investigator Grants |
2023 |
Massachusetts |
Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia |
National Cancer Institute / Christopher Chien, PhD |
Young Investigator Grants |
2014 |
Maryland |